Last reviewed · How we verify

NCT04981587

Effects of Strength Exercise on Fall Risk in Elderly With Alzheimer's Disease

Completed NA Last updated 7 March 2022
What this trial tests

NA trial testing Strength exercise in Alzheimer Disease in 64 participants. Completed in 4 March 2022.

Timeline
1 May 2021
Primary endpoint
10 December 2021
4 March 2022

Quick facts

Lead sponsorUniversity of Jaén
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment64
Start date1 May 2021
Primary completion10 December 2021
Estimated completion4 March 2022
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Jaén

Who can join

60 and older, any sex, with Alzheimer Disease or Dementia; Alzheimer's Type (Etiology). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interventional study to show the effects of strength exercise on fall risk in elderly with Alzheimer's disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Strength exercise

Trials testing the same drug.

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

Other University of Jaén trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04981587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing